A vaccine to tackle the runaway Ebola virus now surging through central Africa can be developed within 100 days, an international disease response group vowed Friday.
The Coalition for Epidemic Preparedness Innovations (CEPI) funds the development of new vaccines and is looking at potential candidates for the Bundibugyo strain, for which there is no current known vaccine.
The outbreak has resulted in 160 suspected deaths out of 670 suspected cases, of which 61 have been confirmed, according to Democratic Republic of Congo (DRC) health ministry data published on Thursday.
Read the full article at BREITBART.COM
